Ildong Pharmaceutical Co., Ltd. (KRX:249420)
South Korea · Delayed Price · Currency is KRW 21,650
-50 (-0.23%)
Last updated: Sep 9, 2025, 2:22 PM KST
Ildong Pharmaceutical Revenue
Ildong Pharmaceutical had revenue of 138.48B KRW in the quarter ending June 30, 2025, a decrease of -8.98%. This brings the company's revenue in the last twelve months to 586.15B, down -2.93% year-over-year. In the year 2024, Ildong Pharmaceutical had annual revenue of 614.94B with 2.36% growth.
Revenue (ttm)
586.15B
Revenue Growth
-2.93%
P/S Ratio
1.14
Revenue / Employee
549.34M
Employees
1,067
Market Cap
670.16B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 614.94B | 14.18B | 2.36% |
| Dec 31, 2023 | 600.76B | -36.96B | -5.80% |
| Dec 31, 2022 | 637.71B | 77.58B | 13.85% |
| Dec 31, 2021 | 560.13B | -1.71B | -0.30% |
| Dec 31, 2020 | 561.85B | 44.38B | 8.58% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 5,031.69B |
| Celltrion | 3,748.95B |
| ALTEOGEN | 158.06B |
| Yuhan | 2,165.44B |
| SK Biopharmaceuticals | 620.28B |
| PharmaResearch | 449.81B |
| Peptron | 5.18B |
| LigaChem Biosciences | 148.28B |